Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-11 Sale |
2021-05-13 4:43 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $19.9 | $597,101 | 992,858 (Direct) |
View |
| 2021-04-22 Sale |
2021-04-23 4:39 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $22.07 | $331,100 | 82,739 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 5:53 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $24.46 | $733,768 | 1,082,858 (Direct) |
View |
| 2021-03-23 Sale |
2021-03-24 4:47 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $21.94 | $329,060 | 97,739 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 5:10 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $22.95 | $344,192 | 149,663 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 5:49 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
31,040 | $29.81 | $925,238 | 156,179 (Direct) |
View |
| 2021-01-22 Sale |
2021-01-22 6:47 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $20.64 | $309,591 | 81,719 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 5:31 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $21.01 | $630,288 | 616,585 (Direct) |
View |
| 2020-12-24 Sale |
2020-12-29 4:50 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
924 | $20.1 | $18,572 | 5,266 (Indirect) |
View |
| 2020-12-22 Sale |
2020-12-23 6:54 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
32,092 | $20.27 | $650,458 | 6,190 (Indirect) |
View |
| 2020-12-15 Sale |
2020-12-17 6:01 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO |
30,000 | $19.53 | $585,986 | 335,299 (Direct) |
View |
| 2020-12-10 Sale |
2020-12-11 4:50 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Ch. Medical Officer & SVP R&D |
9,000 | $20.06 | $180,550 | 85,719 (Direct) |
View |
| 2020-12-08 Sale |
2020-12-10 5:30 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
19,480 | $20.22 | $393,899 | 38,282 (Indirect) |
View |
| 2020-12-01 Sale |
2020-12-03 4:20 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
520 | $20.09 | $10,449 | 57,762 (Indirect) |
View |
| 2020-11-18 Purchase |
2020-11-19 4:54 pm |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
50,000 | $13.5 | $675,000 | 170,969 (Direct) |
View |
| 2020-11-10 Purchase |
2020-11-13 4:33 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. Director |
8,000 | $12.8 | $102,375 | 8,000 (Direct) |
View |
| 2020-09-04 Purchase |
2020-09-08 8:38 pm |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
1,000 | $14.95 | $14,950 | 4,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-11 Exercise |
2021-05-13 4:43 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0.39 | 992,858 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:43 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0 | 992,858 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-11 4:23 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
10,000 | $0.3 | 118,300 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-11 4:23 pm |
N/A 2025-02-27 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
10,000 | $0 | 118,300 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-23 4:39 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $0.39 | 82,739 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-23 4:39 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $0 | 82,739 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 5:53 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0.39 | 1,082,858 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 5:53 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0 | 1,082,858 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 4:47 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $0.39 | 97,739 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 4:47 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $0 | 97,739 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
10,405 | $0.39 | 149,663 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
4,595 | $4.17 | 149,663 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:10 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $0 | 149,663 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:54 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
3,000 | $3.72 | 25,333 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:54 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
3,000 | $0 | 25,333 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 5:49 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
31,040 | $3.72 | 156,179 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 5:49 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
31,040 | $0 | 156,179 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:07 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
3,100 | $0.39 | 123,144 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:07 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
3,100 | $0 | 123,144 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-22 6:47 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $4.17 | 81,719 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-22 6:47 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
15,000 | $0 | 81,719 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 5:31 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $3.72 | 616,585 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 5:31 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
4,000 | $0.39 | 616,585 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 5:31 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
34,000 | $0 | 616,585 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:25 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
69,000 | $0 | 80,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:22 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | Gupta Soma Chief Commercial Officer |
69,000 | $0 | 69,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:18 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
69,000 | $0 | 73,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:14 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
69,000 | $0 | 98,200 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:12 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
69,000 | $0 | 69,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:10 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
69,000 | $0 | 69,000 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-05 5:09 pm |
N/A 2031-01-01 |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
533,333 | $0 | 541,333 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 6:01 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO |
30,000 | $3.72 | 335,299 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 6:01 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO |
30,000 | $0 | 335,299 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-11 4:50 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Ch. Medical Officer & SVP R&D |
9,000 | $4.17 | 85,719 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-11 4:50 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Ch. Medical Officer & SVP R&D |
9,000 | $0 | 85,719 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:42 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:40 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:39 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:38 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:37 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | Deese Willie A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:34 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:32 pm |
N/A 2030-06-11 |
G1 Therapeutics Inc. | GTHX | ESHELMAN FREDRIC N Director |
20,000 | $0 | 20,000 (Direct) |
View |